论文部分内容阅读
硝苯吡啶(心痛定)是一种抗心绞痛药,近年来文献报道有抗高血压作用;与β-阻滞剂等联合使用可减少药物副作用。近三年来我们应用该药治疗高血压患者50例,其抗高血压疗效肯定,副作用少。现小结报道如下。临床资料本文50例高血压病均系住院患者,平均年龄56岁(38~74岁),平均病程8.5年(1~24年)。其中高血压Ⅰ期10例,Ⅱ期35例,Ⅲ期5例。诊断及分期符合1979年郑州会议标准。一、观察方法本组患者入院后停用一切降压药一周,再连续3天测血压,每天一次,心率则取平均值确定为基础血压及心率值。本组随机分二组,即硝苯吡啶组和合并用药组。治疗期间第一周每
Nifedipine (nifedipine) is an anti-anginal drug reported in the literature in recent years, anti-hypertensive effect; and β-blockers and other combinations can reduce drug side effects. In the past three years, we applied the drug to treat 50 cases of patients with hypertension, its anti-hypertensive efficacy is confirmed, fewer side effects. Now summarized as follows. Clinical data of 50 cases of hypertensive patients were hospitalized patients, mean age 56 years (38 to 74 years), the average duration of 8.5 years (1 to 24 years). Among them, there were 10 cases of stage Ⅰ hypertension, 35 cases of stage Ⅱ and 5 cases of stage Ⅲ. Diagnosis and staging meet the 1979 Zhengzhou Conference standard. First, the observation method All patients in this group to disable all antihypertensive drugs after admission for a week, and then for 3 days to measure blood pressure, once daily, the heart rate is taken as the mean to determine the basis of blood pressure and heart rate. This group were randomly divided into two groups, nifedipine group and combination group. During the first week of treatment